Trial Profile
Randomized, Double Blind, Multicenter, Placebo Controlled, Proof of Concept Trial to Assess the Efficacy and Safety of 4 Weeks Treatment With AUS 131 (S Equol) on Benign Prostatic Hyperplasia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs AUS 131 (Primary)
- Indications Benign prostatic hyperplasia
- Focus Proof of concept; Therapeutic Use
- Sponsors Ausio Pharmaceuticals
- 08 Jan 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 12 Feb 2015 Planned End Date changed from 1 Feb 2015 to 1 Jun 2016 as reported by ClinicalTrials.gov record.
- 12 Feb 2015 Planned primary completion date changed from 1 Dec 2014 to 1 Dec 2015 as reported by ClinicalTrials.gov record.